| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |